Niklas Mattsson-Carlgren
151 – 184 of 184
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- « previous
- 1
- 2
- 3
- 4
- next »
- 2018
-
Mark
Apolipoprotein E genotypes and longevity across dementia disorders
(
- Contribution to journal › Article
-
Mark
The National Institute on Aging and the Alzheimer's Association Research Framework for Alzheimer's disease : Perspectives from the Research Roundtable
(
- Contribution to journal › Scientific review
-
Mark
Amyloid pathology in the progression to mild cognitive impairment
(
- Contribution to journal › Article
-
Mark
Association of cerebral amyloid-β Aggregation with cognitive functioning in persons without dementia
(
- Contribution to journal › Article
- 2017
-
Mark
Cerebrospinal fluid neurofilament light concentration in motor neuron disease and frontotemporal dementia predicts survival
(
- Contribution to journal › Article
-
Mark
Ex vivo 18O-labeling mass spectrometry identifies a peripheral amyloid β clearance pathway
(
- Contribution to journal › Article
-
Mark
Effects of surgery and propofol-remifentanil total intravenous anesthesia on cerebrospinal fluid biomarkers of inflammation, Alzheimer's disease, and neuronal injury in humans : A cohort study
(
- Contribution to journal › Article
-
Mark
Serum tau and neurological outcome in cardiac arrest
(
- Contribution to journal › Article
-
Mark
Preclinical effects of APOE ϵ4 on cerebrospinal fluid Aβ42 concentrations
(
- Contribution to journal › Article
-
Mark
Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity
(
- Contribution to journal › Article
-
Mark
A novel quantification-driven proteomic strategy identifies an endogenous peptide of pleiotrophin as a new biomarker of Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
18F-AV-1451 and CSF T-tau and P-tau as biomarkers in Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
CSF/serum albumin ratio in dementias : a cross-sectional study on 1861 patients
(
- Contribution to journal › Article
-
Mark
Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers
(
- Contribution to journal › Scientific review
-
Mark
Cortical Atrophy is Associated with Accelerated Cognitive Decline in Mild Cognitive Impairment with Subsyndromal Depression
(
- Contribution to journal › Article
-
Mark
Time to amyloid positivity and preclinical changes in brain metabolism, atrophy, and cognition : Evidence for emerging amyloid pathology in alzheimer's disease
(
- Contribution to journal › Article
- 2016
-
Mark
Increased amyloidogenic APP processing in APOE ɛ4-negative individuals with cerebral β-amyloidosis.
(
- Contribution to journal › Article
-
Mark
Cerebral amyloid burden and Alzheimer's disease subtypes - does localization information matter?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
CSF Aβ42/Aβ40 and Aβ42/Aβ38 ratios : better diagnostic markers of Alzheimer disease
(
- Contribution to journal › Article
-
Mark
Chronic Depressive Symptomatology in Mild Cognitive Impairment Is Associated with Frontal Atrophy Rate which Hastens Conversion to Alzheimer Dementia
(
- Contribution to journal › Article
-
Mark
Cognitive and functional changes associated with Aβ pathology and the progression to mild cognitive impairment
(
- Contribution to journal › Article
-
Mark
Assessing risk for preclinical β-amyloid pathology with APOE, cognitive, and demographic information
(
- Contribution to journal › Article
-
Mark
Serum neurofilament light protein predicts clinical outcome in traumatic brain injury
(
- Contribution to journal › Article
-
Mark
Reply : Do we still need positron emission tomography for early Alzheimer's disease diagnosis?
(
- Contribution to journal › Letter
-
Mark
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Plasma tau in Alzheimer disease
(
- Contribution to journal › Article
-
Mark
Association of cerebrospinal fluid neurofilament light concentration with Alzheimer disease progression
(
- Contribution to journal › Article
-
Mark
Accelerating rates of cognitive decline and imaging markers associated with β-amyloid pathology
(
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid analysis detects cerebral amyloid-β accumulation earlier than positron emission tomography.
(
- Contribution to journal › Article
-
Mark
Selective vulnerability in neurodegeneration: insights from clinical variants of Alzheimer's disease.
(
- Contribution to journal › Scientific review
- 2015
-
Mark
Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis.
(
- Contribution to journal › Article
-
Mark
Amyloid biomarkers in Alzheimer's disease.
(
- Contribution to journal › Scientific review
-
Mark
Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease.
(
- Contribution to journal › Article
- 2010
-
Mark
Convergence of chromogranin and amyloid metabolism in the brain.
2010) Alzheimer's Association International Conference on Alzheimer's Disease 2010 In Alzheimer's & Dementia 6(4). p.511-511(
- Contribution to journal › Published meeting abstract
- « previous
- 1
- 2
- 3
- 4
- next »